

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.86239218 |
| 2 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 5.85931414 |
| 3 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 5.85931414 |
| 4 | proteasome assembly (GO:0043248) | 4.56586430 |
| 5 | respiratory chain complex IV assembly (GO:0008535) | 4.00579817 |
| 6 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.93532575 |
| 7 | rRNA modification (GO:0000154) | 3.89953609 |
| 8 | cullin deneddylation (GO:0010388) | 3.85494248 |
| 9 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.84501234 |
| 10 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.82018746 |
| 11 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.82018746 |
| 12 | NADH dehydrogenase complex assembly (GO:0010257) | 3.82018746 |
| 13 | mitochondrial RNA metabolic process (GO:0000959) | 3.79968694 |
| 14 | platelet dense granule organization (GO:0060155) | 3.68849204 |
| 15 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.63359360 |
| 16 | ATP synthesis coupled proton transport (GO:0015986) | 3.63359360 |
| 17 | protein deneddylation (GO:0000338) | 3.58569940 |
| 18 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.58326002 |
| 19 | protein complex biogenesis (GO:0070271) | 3.53790787 |
| 20 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.51397634 |
| 21 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.48689780 |
| 22 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.47951763 |
| 23 | behavioral response to nicotine (GO:0035095) | 3.44838344 |
| 24 | adenosine metabolic process (GO:0046085) | 3.43496443 |
| 25 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.43276109 |
| 26 | protein-cofactor linkage (GO:0018065) | 3.36652311 |
| 27 | rRNA methylation (GO:0031167) | 3.34903070 |
| 28 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.33884037 |
| 29 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.32624386 |
| 30 | tRNA processing (GO:0008033) | 3.28253280 |
| 31 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.26342649 |
| 32 | amino acid salvage (GO:0043102) | 3.24530296 |
| 33 | L-methionine salvage (GO:0071267) | 3.24530296 |
| 34 | L-methionine biosynthetic process (GO:0071265) | 3.24530296 |
| 35 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.19418806 |
| 36 | protein neddylation (GO:0045116) | 3.18893588 |
| 37 | tRNA modification (GO:0006400) | 3.18331593 |
| 38 | pseudouridine synthesis (GO:0001522) | 3.16884969 |
| 39 | fucose catabolic process (GO:0019317) | 3.09010524 |
| 40 | L-fucose metabolic process (GO:0042354) | 3.09010524 |
| 41 | L-fucose catabolic process (GO:0042355) | 3.09010524 |
| 42 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.08033409 |
| 43 | IMP biosynthetic process (GO:0006188) | 3.04351217 |
| 44 | chaperone-mediated protein transport (GO:0072321) | 3.02268434 |
| 45 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.00584690 |
| 46 | cytochrome complex assembly (GO:0017004) | 2.99850562 |
| 47 | cytidine deamination (GO:0009972) | 2.97122443 |
| 48 | cytidine metabolic process (GO:0046087) | 2.97122443 |
| 49 | cytidine catabolic process (GO:0006216) | 2.97122443 |
| 50 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.96546479 |
| 51 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.96546479 |
| 52 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.96546479 |
| 53 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.95816910 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 2.94777862 |
| 55 | tRNA metabolic process (GO:0006399) | 2.94032139 |
| 56 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.92357701 |
| 57 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.90972911 |
| 58 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.90972911 |
| 59 | mannosylation (GO:0097502) | 2.90696389 |
| 60 | piRNA metabolic process (GO:0034587) | 2.89924337 |
| 61 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.89682618 |
| 62 | termination of RNA polymerase III transcription (GO:0006386) | 2.89578625 |
| 63 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.89578625 |
| 64 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.89401399 |
| 65 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.89401399 |
| 66 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.89104919 |
| 67 | kynurenine metabolic process (GO:0070189) | 2.82343048 |
| 68 | GPI anchor metabolic process (GO:0006505) | 2.79008760 |
| 69 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.78526023 |
| 70 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.78526023 |
| 71 | branched-chain amino acid catabolic process (GO:0009083) | 2.77751315 |
| 72 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.77305112 |
| 73 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.75221657 |
| 74 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.74879931 |
| 75 | negative regulation of ligase activity (GO:0051352) | 2.74879931 |
| 76 | DNA double-strand break processing (GO:0000729) | 2.74531886 |
| 77 | purine nucleotide salvage (GO:0032261) | 2.74098319 |
| 78 | GPI anchor biosynthetic process (GO:0006506) | 2.73913658 |
| 79 | protein targeting to mitochondrion (GO:0006626) | 2.70967876 |
| 80 | positive regulation of defense response to virus by host (GO:0002230) | 2.67796724 |
| 81 | DNA damage response, detection of DNA damage (GO:0042769) | 2.67327302 |
| 82 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.66432276 |
| 83 | electron transport chain (GO:0022900) | 2.65963774 |
| 84 | organelle disassembly (GO:1903008) | 2.63878139 |
| 85 | establishment of protein localization to mitochondrion (GO:0072655) | 2.63448085 |
| 86 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.63330460 |
| 87 | respiratory electron transport chain (GO:0022904) | 2.63028371 |
| 88 | prenylation (GO:0097354) | 2.62348261 |
| 89 | protein prenylation (GO:0018342) | 2.62348261 |
| 90 | protein localization to mitochondrion (GO:0070585) | 2.61667069 |
| 91 | positive regulation of interleukin-17 production (GO:0032740) | 2.58754346 |
| 92 | S-adenosylmethionine metabolic process (GO:0046500) | 2.58664668 |
| 93 | ketone body metabolic process (GO:1902224) | 2.58604876 |
| 94 | GTP biosynthetic process (GO:0006183) | 2.58579413 |
| 95 | IMP metabolic process (GO:0046040) | 2.57158773 |
| 96 | regulation of immunoglobulin secretion (GO:0051023) | 2.56912121 |
| 97 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.53155144 |
| 98 | methionine biosynthetic process (GO:0009086) | 2.53134418 |
| 99 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.52278827 |
| 100 | regulation of cilium movement (GO:0003352) | 2.49822888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.46139424 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.75805638 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.26978908 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.55856134 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.28377672 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.21028162 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.18219669 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.15885498 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.05601446 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.83619834 |
| 11 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.79427312 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.73170690 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.65373469 |
| 14 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.52116236 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.29835736 |
| 16 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.27242642 |
| 17 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.24860129 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.20611919 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.19349080 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.07270188 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.00477617 |
| 22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95342598 |
| 23 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.86516935 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.82360576 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.81730477 |
| 26 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.67239820 |
| 27 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.59669078 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.57465115 |
| 29 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.56572085 |
| 30 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55887380 |
| 31 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.55650183 |
| 32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.53806325 |
| 33 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.53497110 |
| 34 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.53291575 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.50916806 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50351465 |
| 37 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.49275445 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48355869 |
| 39 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.48203782 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44299538 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.44142746 |
| 42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.42649205 |
| 43 | EWS_26573619_Chip-Seq_HEK293_Human | 1.39641068 |
| 44 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.37572729 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35964979 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32738961 |
| 47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32185484 |
| 48 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.30611774 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28539194 |
| 50 | AR_20517297_ChIP-Seq_VCAP_Human | 1.27975725 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27037243 |
| 52 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.26684768 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23889039 |
| 54 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.22637929 |
| 55 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.22422985 |
| 56 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.21605517 |
| 57 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.21605517 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18770167 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18079360 |
| 60 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17804654 |
| 61 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.15134311 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.13343880 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11399887 |
| 64 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.10082930 |
| 65 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06770753 |
| 66 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.06564198 |
| 67 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.06165174 |
| 68 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05376250 |
| 69 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05376250 |
| 70 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04764816 |
| 71 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.04641626 |
| 72 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03385746 |
| 73 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03385746 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02914725 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.02363228 |
| 76 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02111117 |
| 77 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.01603373 |
| 78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97996066 |
| 79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97397350 |
| 80 | MYB_26560356_Chip-Seq_TH2_Human | 0.97105602 |
| 81 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.96881978 |
| 82 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96165462 |
| 83 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.95902338 |
| 84 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.95581377 |
| 85 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.94160034 |
| 86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.94126988 |
| 87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94051155 |
| 88 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93936324 |
| 89 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93767274 |
| 90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92766617 |
| 91 | GATA3_26560356_Chip-Seq_TH1_Human | 0.92281535 |
| 92 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92209001 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90158498 |
| 94 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.89819012 |
| 95 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.89270296 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89054233 |
| 97 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.88027842 |
| 98 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.87458768 |
| 99 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.87243669 |
| 100 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.86283618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005646_abnormal_pituitary_gland | 4.20697762 |
| 2 | MP0005645_abnormal_hypothalamus_physiol | 3.95944223 |
| 3 | MP0004147_increased_porphyrin_level | 3.88991800 |
| 4 | MP0008877_abnormal_DNA_methylation | 3.05572166 |
| 5 | MP0002102_abnormal_ear_morphology | 2.90070476 |
| 6 | MP0006072_abnormal_retinal_apoptosis | 2.61897544 |
| 7 | MP0003786_premature_aging | 2.54025377 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.41185091 |
| 9 | MP0003724_increased_susceptibility_to | 2.23840420 |
| 10 | MP0008995_early_reproductive_senescence | 2.17252669 |
| 11 | MP0002736_abnormal_nociception_after | 2.16271806 |
| 12 | MP0008872_abnormal_physiological_respon | 2.14827937 |
| 13 | MP0005084_abnormal_gallbladder_morpholo | 2.05749925 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.02800268 |
| 15 | MP0001968_abnormal_touch/_nociception | 1.89614863 |
| 16 | MP0004885_abnormal_endolymph | 1.87554266 |
| 17 | MP0003646_muscle_fatigue | 1.80575943 |
| 18 | MP0008058_abnormal_DNA_repair | 1.78741613 |
| 19 | MP0005671_abnormal_response_to | 1.77928543 |
| 20 | MP0003718_maternal_effect | 1.77777287 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 1.75617450 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.75576737 |
| 23 | MP0010094_abnormal_chromosome_stability | 1.67215802 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.67110111 |
| 25 | MP0002006_tumorigenesis | 1.66560470 |
| 26 | MP0005253_abnormal_eye_physiology | 1.63169281 |
| 27 | MP0006035_abnormal_mitochondrial_morpho | 1.57543539 |
| 28 | MP0001984_abnormal_olfaction | 1.55552593 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.51946909 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.48797586 |
| 31 | MP0009764_decreased_sensitivity_to | 1.43965984 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 1.36306059 |
| 33 | MP0002277_abnormal_respiratory_mucosa | 1.34037060 |
| 34 | MP0003195_calcinosis | 1.33791789 |
| 35 | MP0000013_abnormal_adipose_tissue | 1.33481951 |
| 36 | MP0003693_abnormal_embryo_hatching | 1.31192956 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.29709208 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.26723376 |
| 39 | MP0001661_extended_life_span | 1.25064177 |
| 40 | MP0001800_abnormal_humoral_immune | 1.25049444 |
| 41 | MP0005389_reproductive_system_phenotype | 1.22759665 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.22686084 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.22037057 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.21135272 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.21037519 |
| 46 | MP0001529_abnormal_vocalization | 1.20904114 |
| 47 | MP0001764_abnormal_homeostasis | 1.20165888 |
| 48 | MP0002160_abnormal_reproductive_system | 1.19614645 |
| 49 | MP0003866_abnormal_defecation | 1.18263534 |
| 50 | MP0001905_abnormal_dopamine_level | 1.16943395 |
| 51 | MP0002272_abnormal_nervous_system | 1.13729098 |
| 52 | MP0003186_abnormal_redox_activity | 1.13179821 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.12619963 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.10666560 |
| 55 | MP0002735_abnormal_chemical_nociception | 1.07828198 |
| 56 | MP0000372_irregular_coat_pigmentation | 1.07283697 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.06953549 |
| 58 | MP0009745_abnormal_behavioral_response | 1.01818253 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.01567247 |
| 60 | MP0004043_abnormal_pH_regulation | 1.00676322 |
| 61 | MP0009785_altered_susceptibility_to | 1.00619927 |
| 62 | MP0008775_abnormal_heart_ventricle | 0.96928118 |
| 63 | MP0003011_delayed_dark_adaptation | 0.96296480 |
| 64 | MP0005332_abnormal_amino_acid | 0.94628740 |
| 65 | MP0001919_abnormal_reproductive_system | 0.92404448 |
| 66 | MP0004957_abnormal_blastocyst_morpholog | 0.92357836 |
| 67 | MP0003878_abnormal_ear_physiology | 0.91490724 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 0.91490724 |
| 69 | MP0004133_heterotaxia | 0.91041037 |
| 70 | MP0002723_abnormal_immune_serum | 0.90836482 |
| 71 | MP0001853_heart_inflammation | 0.90611270 |
| 72 | MP0005360_urolithiasis | 0.88165487 |
| 73 | MP0002452_abnormal_antigen_presenting | 0.86519100 |
| 74 | MP0005647_abnormal_sex_gland | 0.86176427 |
| 75 | MP0000631_abnormal_neuroendocrine_gland | 0.86174594 |
| 76 | MP0001486_abnormal_startle_reflex | 0.85428244 |
| 77 | MP0002733_abnormal_thermal_nociception | 0.83316819 |
| 78 | MP0003763_abnormal_thymus_physiology | 0.83243513 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 0.82905146 |
| 80 | MP0000647_abnormal_sebaceous_gland | 0.79913452 |
| 81 | MP0003252_abnormal_bile_duct | 0.79496316 |
| 82 | MP0004142_abnormal_muscle_tone | 0.78017549 |
| 83 | MP0001790_abnormal_immune_system | 0.77423323 |
| 84 | MP0005387_immune_system_phenotype | 0.77423323 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.74975797 |
| 86 | MP0000685_abnormal_immune_system | 0.74938303 |
| 87 | MP0008057_abnormal_DNA_replication | 0.74523800 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.73917847 |
| 89 | MP0009046_muscle_twitch | 0.73890628 |
| 90 | MP0000689_abnormal_spleen_morphology | 0.73252874 |
| 91 | MP0001819_abnormal_immune_cell | 0.72646493 |
| 92 | MP0001243_abnormal_dermal_layer | 0.71699001 |
| 93 | MP0003787_abnormal_imprinting | 0.71549267 |
| 94 | MP0005670_abnormal_white_adipose | 0.70817887 |
| 95 | MP0002420_abnormal_adaptive_immunity | 0.70496599 |
| 96 | MP0001119_abnormal_female_reproductive | 0.70258064 |
| 97 | MP0005410_abnormal_fertilization | 0.69792988 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.69006739 |
| 99 | MP0002163_abnormal_gland_morphology | 0.68514627 |
| 100 | MP0001929_abnormal_gametogenesis | 0.68462592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of alanine metabolism (HP:0010916) | 4.22107198 |
| 2 | Hyperalaninemia (HP:0003348) | 4.22107198 |
| 3 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.22107198 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 3.72160607 |
| 5 | Mitochondrial inheritance (HP:0001427) | 3.59302975 |
| 6 | Increased CSF lactate (HP:0002490) | 3.54820691 |
| 7 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.46293942 |
| 8 | Methylmalonic acidemia (HP:0002912) | 3.44392018 |
| 9 | Acute encephalopathy (HP:0006846) | 3.35409777 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.33232456 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.30764484 |
| 12 | Lipid accumulation in hepatocytes (HP:0006561) | 3.29058425 |
| 13 | 3-Methylglutaconic aciduria (HP:0003535) | 3.26689244 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.15173325 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.14544603 |
| 16 | Progressive macrocephaly (HP:0004481) | 3.03448023 |
| 17 | IgG deficiency (HP:0004315) | 2.99352248 |
| 18 | Increased serum lactate (HP:0002151) | 2.99304902 |
| 19 | Renal cortical cysts (HP:0000803) | 2.98467163 |
| 20 | Hepatic necrosis (HP:0002605) | 2.96867504 |
| 21 | Methylmalonic aciduria (HP:0012120) | 2.83302250 |
| 22 | Pancreatic cysts (HP:0001737) | 2.79300473 |
| 23 | Pendular nystagmus (HP:0012043) | 2.77586440 |
| 24 | Lactic acidosis (HP:0003128) | 2.75527901 |
| 25 | Abnormality of serum amino acid levels (HP:0003112) | 2.67510890 |
| 26 | Tubulointerstitial nephritis (HP:0001970) | 2.63888185 |
| 27 | Constricted visual fields (HP:0001133) | 2.60442579 |
| 28 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.60124987 |
| 29 | Type 2 muscle fiber atrophy (HP:0003554) | 2.58136953 |
| 30 | Cerebral edema (HP:0002181) | 2.57093488 |
| 31 | True hermaphroditism (HP:0010459) | 2.56398855 |
| 32 | Pancreatic fibrosis (HP:0100732) | 2.55719731 |
| 33 | Opisthotonus (HP:0002179) | 2.54282924 |
| 34 | Nephronophthisis (HP:0000090) | 2.49665602 |
| 35 | Abnormality of the renal cortex (HP:0011035) | 2.44821110 |
| 36 | Progressive microcephaly (HP:0000253) | 2.44781255 |
| 37 | Abnormality of midbrain morphology (HP:0002418) | 2.41095906 |
| 38 | Molar tooth sign on MRI (HP:0002419) | 2.41095906 |
| 39 | Attenuation of retinal blood vessels (HP:0007843) | 2.36697099 |
| 40 | Type II lissencephaly (HP:0007260) | 2.33059787 |
| 41 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.27113330 |
| 42 | Type I transferrin isoform profile (HP:0003642) | 2.26648131 |
| 43 | Medial flaring of the eyebrow (HP:0010747) | 2.25669561 |
| 44 | Dicarboxylic aciduria (HP:0003215) | 2.23642068 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.23642068 |
| 46 | Abolished electroretinogram (ERG) (HP:0000550) | 2.23342428 |
| 47 | Chronic hepatic failure (HP:0100626) | 2.21469950 |
| 48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.20738146 |
| 49 | Abnormality of the pons (HP:0007361) | 2.18868205 |
| 50 | Renal Fanconi syndrome (HP:0001994) | 2.17884095 |
| 51 | Abnormality of the renal medulla (HP:0100957) | 2.17189772 |
| 52 | Congenital stationary night blindness (HP:0007642) | 2.17189632 |
| 53 | Respiratory failure (HP:0002878) | 2.17104911 |
| 54 | Decreased central vision (HP:0007663) | 2.14020361 |
| 55 | Hyperglycinemia (HP:0002154) | 2.13462152 |
| 56 | Increased intramyocellular lipid droplets (HP:0012240) | 2.12547574 |
| 57 | Lethargy (HP:0001254) | 2.12404563 |
| 58 | Nausea (HP:0002018) | 2.10918552 |
| 59 | Keratoconus (HP:0000563) | 2.10529255 |
| 60 | Increased corneal curvature (HP:0100692) | 2.10529255 |
| 61 | Stomatitis (HP:0010280) | 2.08161640 |
| 62 | Inability to walk (HP:0002540) | 2.07081785 |
| 63 | Abnormal biliary tract physiology (HP:0012439) | 2.05996202 |
| 64 | Bile duct proliferation (HP:0001408) | 2.05996202 |
| 65 | Metabolic acidosis (HP:0001942) | 2.05561855 |
| 66 | Muscle fiber atrophy (HP:0100295) | 2.04676586 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.03971968 |
| 68 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.03524236 |
| 69 | Optic disc pallor (HP:0000543) | 2.03429633 |
| 70 | Exercise intolerance (HP:0003546) | 2.01089010 |
| 71 | Duplicated collecting system (HP:0000081) | 1.97633898 |
| 72 | Homocystinuria (HP:0002156) | 1.97029418 |
| 73 | Abnormality of homocysteine metabolism (HP:0010919) | 1.97029418 |
| 74 | Exertional dyspnea (HP:0002875) | 1.96134831 |
| 75 | Cerebral palsy (HP:0100021) | 1.95848498 |
| 76 | Congenital, generalized hypertrichosis (HP:0004540) | 1.94834167 |
| 77 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.94587008 |
| 78 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.94587008 |
| 79 | Abnormal protein glycosylation (HP:0012346) | 1.94587008 |
| 80 | Abnormal glycosylation (HP:0012345) | 1.94587008 |
| 81 | Hypoplasia of the pons (HP:0012110) | 1.91852534 |
| 82 | Abnormality of the renal collecting system (HP:0004742) | 1.90618676 |
| 83 | Abnormality of vitamin B metabolism (HP:0004340) | 1.89947767 |
| 84 | Microvesicular hepatic steatosis (HP:0001414) | 1.89655400 |
| 85 | Abnormality of urine glucose concentration (HP:0011016) | 1.88670404 |
| 86 | Glycosuria (HP:0003076) | 1.88670404 |
| 87 | Increased serum pyruvate (HP:0003542) | 1.87649892 |
| 88 | Stomach cancer (HP:0012126) | 1.87019526 |
| 89 | Degeneration of anterior horn cells (HP:0002398) | 1.86006649 |
| 90 | Abnormality of the anterior horn cell (HP:0006802) | 1.86006649 |
| 91 | Carpal bone hypoplasia (HP:0001498) | 1.85369926 |
| 92 | Panhypogammaglobulinemia (HP:0003139) | 1.83588033 |
| 93 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.83189740 |
| 94 | Increased muscle lipid content (HP:0009058) | 1.82443384 |
| 95 | Anorexia (HP:0002039) | 1.78585705 |
| 96 | Reduced antithrombin III activity (HP:0001976) | 1.77713016 |
| 97 | Abnormality of glycine metabolism (HP:0010895) | 1.77399135 |
| 98 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.77399135 |
| 99 | Testicular atrophy (HP:0000029) | 1.76716489 |
| 100 | Colon cancer (HP:0003003) | 1.75330307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 3.65380430 |
| 2 | TLK1 | 3.33317190 |
| 3 | ADRBK2 | 2.84184359 |
| 4 | EIF2AK3 | 2.78654541 |
| 5 | TXK | 2.72590276 |
| 6 | NUAK1 | 2.46165831 |
| 7 | TAOK3 | 2.43665067 |
| 8 | BUB1 | 2.34421944 |
| 9 | VRK2 | 2.26912908 |
| 10 | TIE1 | 2.22603135 |
| 11 | MAP4K2 | 2.18512132 |
| 12 | TSSK6 | 2.12782602 |
| 13 | NEK1 | 1.69895378 |
| 14 | GRK1 | 1.69883488 |
| 15 | SRPK1 | 1.69757195 |
| 16 | MST4 | 1.67550075 |
| 17 | WNK4 | 1.56743909 |
| 18 | VRK1 | 1.56473131 |
| 19 | KDR | 1.48299715 |
| 20 | BCKDK | 1.44185726 |
| 21 | TEC | 1.43140194 |
| 22 | MKNK1 | 1.42532103 |
| 23 | CSNK1G3 | 1.42219867 |
| 24 | MAP3K14 | 1.36638628 |
| 25 | STK16 | 1.28015075 |
| 26 | CSNK1A1L | 1.26177082 |
| 27 | MAPKAPK5 | 1.23927959 |
| 28 | IKBKB | 1.23501060 |
| 29 | BCR | 1.22328306 |
| 30 | NME1 | 1.22312241 |
| 31 | CCNB1 | 1.22168330 |
| 32 | CSNK1G1 | 1.21007258 |
| 33 | CSNK1G2 | 1.20864579 |
| 34 | PLK3 | 1.16322930 |
| 35 | DAPK1 | 1.12558084 |
| 36 | EIF2AK2 | 1.10476768 |
| 37 | FRK | 1.10273711 |
| 38 | RPS6KA5 | 1.08919041 |
| 39 | WNK3 | 1.07892725 |
| 40 | MAP2K7 | 1.07252498 |
| 41 | ITK | 1.06717030 |
| 42 | TESK2 | 1.05443861 |
| 43 | PHKG2 | 1.03205526 |
| 44 | PHKG1 | 1.03205526 |
| 45 | FES | 1.00876010 |
| 46 | GRK6 | 0.99408138 |
| 47 | ERBB3 | 0.98671929 |
| 48 | TRIM28 | 0.98158081 |
| 49 | EIF2AK1 | 0.97287140 |
| 50 | PLK4 | 0.96179760 |
| 51 | MAP4K1 | 0.94143991 |
| 52 | MAPKAPK3 | 0.91134209 |
| 53 | MAP3K4 | 0.90088972 |
| 54 | ADRBK1 | 0.88873193 |
| 55 | PINK1 | 0.87690585 |
| 56 | BMPR2 | 0.86714383 |
| 57 | CAMKK2 | 0.86533090 |
| 58 | CLK1 | 0.84023278 |
| 59 | ATR | 0.84016094 |
| 60 | BMPR1B | 0.82773546 |
| 61 | SYK | 0.82163776 |
| 62 | OXSR1 | 0.81702058 |
| 63 | PBK | 0.76440606 |
| 64 | PLK2 | 0.76097304 |
| 65 | PASK | 0.73875391 |
| 66 | TTK | 0.68034760 |
| 67 | TBK1 | 0.68031687 |
| 68 | MAP2K2 | 0.64170112 |
| 69 | PRKCQ | 0.64089184 |
| 70 | DYRK2 | 0.62133306 |
| 71 | STK39 | 0.61534158 |
| 72 | OBSCN | 0.59330022 |
| 73 | INSRR | 0.56975512 |
| 74 | PDK2 | 0.56192853 |
| 75 | ALK | 0.56016441 |
| 76 | KIT | 0.55248908 |
| 77 | IKBKE | 0.54056858 |
| 78 | ACVR1B | 0.53831566 |
| 79 | TAF1 | 0.53052305 |
| 80 | MAPK13 | 0.53036543 |
| 81 | PIK3CA | 0.53013674 |
| 82 | JAK3 | 0.51646389 |
| 83 | CSNK1A1 | 0.50274904 |
| 84 | AURKB | 0.50079788 |
| 85 | PLK1 | 0.49672959 |
| 86 | BTK | 0.49568623 |
| 87 | IRAK4 | 0.48678801 |
| 88 | PIK3CG | 0.47654317 |
| 89 | LCK | 0.45810442 |
| 90 | CAMK2A | 0.45665671 |
| 91 | CSNK2A1 | 0.44908209 |
| 92 | LYN | 0.43306310 |
| 93 | PRKCE | 0.42898934 |
| 94 | IGF1R | 0.40937370 |
| 95 | PRKCG | 0.40369335 |
| 96 | TNK2 | 0.39402087 |
| 97 | CSNK2A2 | 0.38614221 |
| 98 | MKNK2 | 0.37656741 |
| 99 | CDK8 | 0.37519742 |
| 100 | PRKCA | 0.37314233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.05897022 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.77536903 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.43642655 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.43537537 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.34871367 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.33079302 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.30891758 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.11844288 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.00534720 |
| 10 | Asthma_Homo sapiens_hsa05310 | 1.90330129 |
| 11 | Protein export_Homo sapiens_hsa03060 | 1.90276225 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87991907 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.72423784 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69277126 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 1.68535765 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.67956492 |
| 17 | RNA degradation_Homo sapiens_hsa03018 | 1.64110761 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.62056348 |
| 19 | Spliceosome_Homo sapiens_hsa03040 | 1.61207121 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.54579820 |
| 21 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.53465778 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.48151936 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.47714701 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47399321 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45869401 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.44990228 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.42462416 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 1.42366939 |
| 29 | Base excision repair_Homo sapiens_hsa03410 | 1.40725336 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.39254526 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.38535712 |
| 32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.37841998 |
| 33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.34803983 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34538316 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.30927052 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.30670090 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.27081978 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25989624 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21637195 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21302019 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21028401 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.18606715 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.18064805 |
| 44 | Purine metabolism_Homo sapiens_hsa00230 | 1.14060434 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13909376 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.13675562 |
| 47 | Ribosome_Homo sapiens_hsa03010 | 1.13638286 |
| 48 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.12076300 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11596719 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08185415 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.06943661 |
| 52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.06901749 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05520368 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04579998 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03696556 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99085862 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99080643 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93820603 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92484478 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.92325164 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92132474 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90461376 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.87563843 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86611435 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85329633 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84399357 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81767338 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79937446 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79865527 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73483875 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73365797 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71655389 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.68499834 |
| 74 | Nicotine addiction_Homo sapiens_hsa05033 | 0.67389875 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65965348 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64464402 |
| 77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62706722 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60714312 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.59227707 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58613887 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56971384 |
| 82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56430631 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.52965295 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51756743 |
| 85 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47718166 |
| 86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46082245 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44871023 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44400336 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44354344 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43031743 |
| 91 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42846891 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42279230 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.42081482 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41833215 |
| 95 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41631525 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41494778 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39334422 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36469489 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36351431 |
| 100 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34004252 |

